The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition

25 Aug 2021


Kalorama Information’s latest edition of our in vitro diagnostic market report represents the fourteenth time in two decades our analysts have fully assessed the in vitro diagnostic market from scratch and re-report numbers.  Last year, the COVID-19 pandemic highlighted how important testing is in a way that could not be imagined  This year, COVID-19 is to some degree a routine test category in respiratory and infectious disease testing, themselves high-growth segments.   Now the question will be how increased back to work/back to school/back to physician office plans will affect IVD markets?  This as well as the segment-specific testing market trends will be addressed in this volume.

What is the Size of the IVD Market in 2021?

This report answers this question and more.  Beyond COVID-19, Tests for cancer and infectious disease detection, transplant success, pharmaceutical selection have added healthcare value and improved outcomes. Genetic tests for rare diseases and prenatal assessment are increasingly utilized. Tests for emerging diseases have also become increasingly important.

What is the Size of IVD Market Segments? Who’s Winning? Who’s Merged? Who’s Launched Game-Changing Products?

One book definitively answers these questions, from a publisher that is focused on in vitro diagnostics.  Now in its 14th edition, this Kalorama Information report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry. For two decades, the 1,500-plus page report has provided reliable estimates and real-world forecasts for the in vitro diagnostics industry.


Page Count: 1792